VYOME HOLDINGS, INC. Sales Revenue, Services, Net (Deprecated 2018-01-31)
VYOME HOLDINGS, INC. (HIND) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $1.35 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2018-05-10
- VYOME HOLDINGS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.35M, a 8.56% decline year-over-year.
- VYOME HOLDINGS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $3.69M.
- VYOME HOLDINGS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.79M.
- VYOME HOLDINGS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $1.96M.
- VYOME HOLDINGS, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2017 was $9.91M.
- VYOME HOLDINGS, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- VYOME HOLDINGS, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2015 was $216.00K, a 87.17% decline from fiscal 2014.
- VYOME HOLDINGS, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2014 was $1.68M.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $1.35M 10-Q · filed 2018-05-10 | $5.04M derived: sum of 2 quarters · filed 2018-05-10 | $7.83M derived: sum of 3 quarters · filed 2018-05-10 | $9.79M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $6.48M derived: sum of 2 quarters · filed 2018-03-05 | $8.44M derived: sum of 3 quarters · filed 2018-03-05 | $9.91M 10-K · filed 2018-03-05 |
| 2017-09-30 | $2.79M 10-Q · filed 2017-11-03 | $4.75M derived: sum of 2 quarters · filed 2017-11-03 | $6.22M 10-Q · filed 2017-11-03 | $6.22M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | $1.96M 10-Q · filed 2017-08-02 | $3.44M 10-Q · filed 2017-08-02 | $3.44M derived: sum of 3 quarters · filed 2018-05-10 | $3.44M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | $1.47M 10-Q · filed 2018-05-10 | $1.47M derived: sum of 2 quarters · filed 2018-05-10 | $1.47M derived: sum of 3 quarters · filed 2018-05-10 | $1.47M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $0.00 derived: sum of 2 quarters · filed 2018-03-05 | $0.00 derived: sum of 3 quarters · filed 2018-03-05 | $0.00 10-K · filed 2018-03-05 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-03 | $0.00 derived: sum of 2 quarters · filed 2017-11-03 | $0.00 10-Q · filed 2017-11-03 | -$8.00K derived: sum of 4 quarters · filed 2018-03-05 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-02 | $0.00 10-Q · filed 2017-08-02 | -$8.00K derived: sum of 3 quarters · filed 2018-03-05 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | -$8.00K derived: sum of 2 quarters · filed 2018-03-05 | ||
| 2015-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $216.00K 10-K · filed 2018-03-05 | ||
| 2015-09-30 | $224.00K 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $1.68M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |